Vikram Punia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vikram Punia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vikram Punia Today - Breaking & Trending Today

Some Russian drugmakers focus on export-oriented Sputnik Light shot

Published: June 9, 2021

(Refiles to add dropped letter in surname of BioIntegrator co-owner)

Source: reuters.com

Russian court rejects US firm's lawsuit over COVID-19 drug remdesivir

Published: May 28, 2021

Russian court rejects US firm's lawsuit over COVID-19 drug remdesivir SECTIONS Last Updated: May 28, 2021, 11:40 PM IST Share Synopsis The Russian government late last year granted Russian drugmaker Pharmasyntez a compulsory licence for one year to manufacture the drug under a different name without Gilead's permission. Pharmasyntez produces remdesivir under the name Remdeform. A shipment of the drug was sent by Russia to India on Tuesday as part of a delivery of humanitarian aid. Russia's Supreme Court on Thursday rejected a lawsuit from U.S. company Gilead Sciences that challenged a Russian...

Source: indiatimes.com

Russian court rejects U.S firm's lawsuit over COVID-19 drug remdesivir

Published: May 27, 2021

Reuters 2 minute read The logo of Gilead Sciences Inc pharmaceutical company is seen in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake/File Photo/File Photo Russia's Supreme Court on Thursday rejected a lawsuit from U.S. company Gilead Sciences (GILD.O)that challengeda Russian government decision to let a Russian firm develop and market the anti-COVID-19 drug remdesivir without Gilead's consent. The Russian government late last year granted Russian drugmaker Pharmasyntez a compulsory licence for one year to manufacture the drug under a different name without Gilead's permissi...

Source: reuters.com

Big promises, few doses: Why Russia is struggling to produce Sputnik V

Published: May 15, 2021

May 15, 2021 Moscow – Transforming the site of what once was a Soviet-era car factory into a state-of-the-art facility churning out Russia’s COVID-19 vaccine Sputnik V was the easy bit. Making doses in bulk, finding qualified staff and getting equipment have been much bigger headaches for Moscow-based biotech firm R-Pharm and other private Russian companies picked to make the country’s flagship shot to fight the pandemic. President Vladimir Putin has trumpeted the vaccine around the world, and said in March that Russia had signed agreements for the production of 700 million dos...

Source: japantimes.co.jp